178 related articles for article (PubMed ID: 16382258)
1. Metabolic modulators for chronic cardiac ischemia.
Parang P; Singh B; Arora R
J Cardiovasc Pharmacol Ther; 2005 Dec; 10(4):217-23. PubMed ID: 16382258
[TBL] [Abstract][Full Text] [Related]
2. Role of metabolically active drugs in the management of ischemic heart disease.
Schofield RS; Hill JA
Am J Cardiovasc Drugs; 2001; 1(1):23-35. PubMed ID: 14728049
[TBL] [Abstract][Full Text] [Related]
3. Ischemic heart disease: metabolic approaches to management.
Pauly DF; Pepine CJ
Clin Cardiol; 2004 Aug; 27(8):439-41. PubMed ID: 15346837
[TBL] [Abstract][Full Text] [Related]
4. The antianginal agent trimetazidine does not exert its functional benefit via inhibition of mitochondrial long-chain 3-ketoacyl coenzyme A thiolase.
MacInnes A; Fairman DA; Binding P; Rhodes Ja; Wyatt MJ; Phelan A; Haddock PS; Karran EH
Circ Res; 2003 Aug; 93(3):e26-32. PubMed ID: 12869391
[TBL] [Abstract][Full Text] [Related]
5. The metabolic treatment of patients with coronary artery disease: effects on quality of life and effort angina.
César LA; Gowdak LH; Mansur AP
Curr Pharm Des; 2009; 15(8):841-9. PubMed ID: 19275648
[TBL] [Abstract][Full Text] [Related]
6. Trimetazidine in the myocardial cell mechanisms of cytoprotection.
Labrid C
Rom J Intern Med; 1998; 36(3-4):137-44. PubMed ID: 10822510
[TBL] [Abstract][Full Text] [Related]
7. Metabolic approach to myocardial ischemia: a novel therapeutic strategy for patients with coronary artery disease?
Rizzon P; Iliceto S; Marangelli V
Cardiologia; 1995 Oct; 40(10):717-20. PubMed ID: 8819732
[No Abstract] [Full Text] [Related]
8. Chronic angina: new medical options for treatment.
McCullough PA
Rev Cardiovasc Med; 2005; 6(3):152-61. PubMed ID: 16195688
[TBL] [Abstract][Full Text] [Related]
9. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
Belardinelli R
Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
[TBL] [Abstract][Full Text] [Related]
10. Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
Lee L; Horowitz J; Frenneaux M
Eur Heart J; 2004 Apr; 25(8):634-41. PubMed ID: 15084367
[TBL] [Abstract][Full Text] [Related]
11. The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure.
Rupp H; Zarain-Herzberg A; Maisch B
Herz; 2002 Nov; 27(7):621-36. PubMed ID: 12439634
[TBL] [Abstract][Full Text] [Related]
12. Metabolic management of ischaemic heart disease.
Chierchia SL; Fragasso G
Eur Heart J; 1993 Nov; 14 Suppl G():2-5. PubMed ID: 7904560
[TBL] [Abstract][Full Text] [Related]
13. [Treating ischemic heart disease by pharmacologically improving cardiac energy metabolism].
Lopaschuk GD
Presse Med; 1998 Dec; 27(39):2100-4. PubMed ID: 9893703
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle.
Fang YH; Piao L; Hong Z; Toth PT; Marsboom G; Bache-Wiig P; Rehman J; Archer SL
J Mol Med (Berl); 2012 Jan; 90(1):31-43. PubMed ID: 21874543
[TBL] [Abstract][Full Text] [Related]
15. Metabolic modulation and optimization of energy consumption in heart failure.
Ferrari R; Cicchitelli G; Merli E; Andreadou I; Guardigli G
Med Clin North Am; 2003 Mar; 87(2):493-507, xii-xiii. PubMed ID: 12693736
[TBL] [Abstract][Full Text] [Related]
16. [Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications].
Lamendola P; Di Monaco A; Barone L; Pisanello C; Lanza GA; Crea F
G Ital Cardiol (Rome); 2009 Jan; 10(1):28-36. PubMed ID: 19292017
[TBL] [Abstract][Full Text] [Related]
17. Metabolic agents in the management of diabetic coronary patients: a new era.
Celik T; Kursaklioglu H; Iyisoy A; Jata B
Int J Cardiol; 2008 Jun; 127(1):133-4. PubMed ID: 17561287
[TBL] [Abstract][Full Text] [Related]
18. [Trimetazidine (Preductal). A new approach in controlling myocardial ischemia].
Eliseev OM
Ter Arkh; 1996; 68(8):57-63. PubMed ID: 9019836
[No Abstract] [Full Text] [Related]
19. Chronic stable angina pectoris.
Jawad E; Arora R
Dis Mon; 2008 Sep; 54(9):671-89. PubMed ID: 18725007
[No Abstract] [Full Text] [Related]
20. [Therapeutic application of myocardial cytoprotection].
Ribeiro C
Rev Port Cardiol; 1994 Sep; 13(9):669-70. PubMed ID: 7818940
[No Abstract] [Full Text] [Related]
[Next] [New Search]
